SG
HRMY icon

StoneX Group’s Harmony Biosciences HRMY Stock Holding History

StoneX Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Sell
12,149
-482
-4% -$15.2K 0.02% 625
2026
Q1 		$354K Buy
+12,631
New +$414K 0.02% 514
2025
Q3 		– Sell
-13,347
Closed -$422K – 968
2025
Q2 		$422K Sell
13,347
-2,226
-14% -$71.6K 0.02% 554
2025
Q1 		$517K Sell
15,573
-5,206
-25% -$187K 0.03% 462
2024
Q4 		$715K Buy
20,779
+1,897
+10% +$65.2K 0.04% 375
2024
Q3 		$755K Buy
+18,882
New +$663K 0.05% 273

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

StoneX Group's HRMY Position: Q2 2026 in Review

StoneX Group reduced its Harmony Biosciences (HRMY) stake by 3.8% in Q2 2026, selling an estimated $15.2K and leaving 12,149 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #625.

StoneX Group first reported a position in HRMY in Q3 2024 and has held it in 6 quarters since. The position peaked at $755K in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • StoneX Group held 12,149 shares of Harmony Biosciences worth $442K as of Q2 2026.
  • StoneX Group sold 482 Harmony Biosciences shares in Q2 2026, an estimated $15.2K.
  • Harmony Biosciences made up 0.02% of StoneX Group's portfolio in Q2 2026, its #625 holding.
  • StoneX Group first reported a position in Harmony Biosciences in Q3 2024 and has held it in 6 quarters since.
  • StoneX Group's Harmony Biosciences position peaked at $755K in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.